Haemonetics Corporation
US ˙ NYSE ˙ US4050241003

SecurityHAE / Haemonetics Corporation
InstitutionNatixis Advisors, L.p.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Natixis Advisors, L.p. closes position in HAE / Haemonetics Corporation

On November 13, 2025 - Natixis Advisors, L.p. filed a 13F-HR form disclosing ownership of 0 shares of Haemonetics Corporation (US:HAE) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 13, 2025 disclosing 11,886 shares of Haemonetics Corporation. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-11-13 2025-09-30 13F HAEMONETICS CORP MASS COM 405024100 0 -100.00 0
2025-08-13 2025-06-30 13F HAEMONETICS CORP MASS COM 405024100 11,886 11,886 1 0.0014
2025-05-08 2025-03-31 13F HAEMONETICS CORP MASS COM 405024100 0 -15,294 -100.00 0 -100.00
2025-02-10 2024-12-31 13F HAEMONETICS CORP MASS COM 405024100 15,294 15,294 1 0.0022
2024-11-06 2024-09-30 13F HAEMONETICS CORP MASS COM 405024100 0 -14,324 -100.00 0 -100.00
2024-08-01 2024-06-30 13F HAEMONETICS CORP MASS COM 405024100 14,324 3,193 28.69 1 0.0026
2024-04-25 2024-03-31 13F HAEMONETICS CORP MASS COM 405024100 11,131 -4,688 -29.64 1 -100.00 0.0022
2024-02-06 2023-12-31 13F HAEMONETICS CORP MASS COM 405024100 15,819 324 2.09 1 0.00 0.0036
2023-11-13 2023-09-30 13F HAEMONETICS COM 405024100 15,495 1,465 10.44 1 0.00 0.0042
2023-08-15 2023-06-30 13F HAEMONETICS CORP MASS COM 405024100 14,030 992 7.61 1 0.00 0.0037
2023-05-11 2023-03-31 13F HAEMONETICS CORP MASS COM 405024100 13,038 13,038 1 0.0037
2021-08-12 2021-06-30 13F HAEMONETICS COM 405024100 0 -15,578 -100.00 0 -100.00
2021-05-05 2021-03-31 13F HAEMONETICS COM 405024100 15,578 -2,740 -14.96 1,729 -20.51 0.0090
2021-02-12 2020-12-31 13F HAEMONETICS COM 405024100 18,318 -644 -3.40 2,175 31.50 0.0125
2020-11-12 2020-09-30 13F HAEMONETICS COM 405024100 18,962 18,962 1,654 0.0104
2018-11-13 2018-09-30 13F HAEMONETICS COM 405024100 0 -13,543 -100.00 0 -100.00
2018-08-14 2018-06-30 13F/A-1 HAEMONETICS COM 405024100 13,543 -11,786 -46.53 1,215 -34.43 0.0116
2018-08-14 2018-06-30 13F HAEMONETICS COM 405024100 13,543 1,215
2018-05-10 2018-03-31 13F HAEMONETICS COM 405024100 25,329 -367 -1.43 1,853 24.20 0.0183
2018-02-14 2017-12-31 13F HAEMONETICS COM 405024100 25,696 421 1.67 1,492 31.57 0.0152
2017-11-14 2017-09-30 13F HAEMONETICS COM 405024100 25,275 2,854 12.73 1,134 28.14 0.0120
2017-07-27 2017-06-30 13F HAEMONETICS COM 405024100 22,421 22,421 885 0.0096
2017-02-07 2016-12-31 13F HAEMONETICS COM 405024100 0 -13,104 -100.00 0 -100.00
2016-11-04 2016-09-30 13F HAEMONETICS COM 405024100 13,104 1,037 8.59 474 35.43 0.0061
2016-08-01 2016-06-30 13F HAEMONETICS COM 405024100 12,067 1,729 16.72 350 -3.31 0.0048
2016-05-06 2016-03-31 13F HAEMONETICS COM 405024100 10,338 10,338 0.00 362 0.0054
2016-02-12 2015-12-31 13F HAEMONETICS COM 405024100 0 0 0 0.0000
2015-11-12 2015-09-30 13F HAEMONETICS COM 405024100 0 -72,371 -100.00 0 -100.00
2015-08-14 2015-06-30 13F HAEMONETICS COM 405024100 72,371 -27,294 -27.39 2,994 -33.12 0.0508
2015-05-15 2015-03-31 13F HAEMONETICS COM 405024100 99,665 -82,075 -45.16 4,477 -34.17 0.0786
2015-02-05 2014-12-31 13F HAEMONETICS COM 405024100 181,740 29,157 19.11 6,801 27.65 0.1273
2014-11-03 2014-09-30 13F HAEMONETICS COM 405024100 152,583 -92,442 -37.73 5,328 -38.36 0.1069
2014-08-13 2014-06-30 13F HAEMONETICS COM 405024100 245,025 239,649 4,457.76 8,644 3,724.78 0.1239
2014-02-12 2013-12-31 13F HAEMONETICS COM 405024100 5,376 177 3.40 226 9.18 0.0037
2013-10-30 2013-09-30 13F HAEMONETICS COM 405024100 5,199 157 3.11 207 -0.96 0.0038
2013-07-19 2013-06-30 13F HAEMONETICS COM 405024100 5,042 5,042 209 0.0042
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.